Results · Apr-Jun 2026 · filed 3 Aug 2026
Krishna Institute of Medical Sciences Q1 FY27 results
Sales grew 35% to ₹1,180 crore from ₹872 crore in Apr-Jun 2025.
Operating profit grew 16% to ₹223 crore, an operating margin of 18.9% (down 3.2 points from a year ago).
Net profit fell 56% to ₹37.4 crore from ₹85 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +10%, net profit +13%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 1,180 | 871.6 | +35% |
| Operating profit (EBITDA) | 223.4 | 192.6 | +16% |
| Operating margin | 18.9% | 22.1% | −3.2 pts |
| Net profit | 37.4 | 85.0 | −56% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 8 Aug 2026Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- 7 Aug 2026Intimation Of Receipt Of The In-Principle Approval From BSE Limited And The National Stock Exchange Of India Limited
- 6 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 5 Aug 2026Letter To Shareholders Regarding Annual Report
- 5 Aug 2026Business Responsibility and Sustainability Reporting (BRSR)
- 5 Aug 2026Reg. 34 (1) Annual Report.
- 5 Aug 202624Th Annual General Meeting Of The Company Scheduled To Be Held On 27Th August 2026
- 4 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.